Horst D - Search Results

1

Urinary Calprotectin loses specificity as tumour marker due to sterile leukocyturia associated with bladder cancer.

Bausch K, Roth E, Heinz S, Horst D, Mathia S, Vlajnic T, Bubendorf L, Westhoff T, Wetterauer C, Seifert HH, Ebbing J. Bausch K, et al. Among authors: horst d. PLoS One. 2019 Mar 14;14(3):e0213549. doi: 10.1371/journal.pone.0213549. eCollection 2019. PLoS One. 2019. PMID: 30870488 Free PMC article. Clinical Trial.

2

Progression of urothelial carcinoma in situ of the urinary bladder: a switch from luminal to basal phenotype and related therapeutic implications.

Barth I, Schneider U, Grimm T, Karl A, Horst D, Gaisa NT, Knüchel R, Garczyk S. Barth I, et al. Among authors: horst d. Virchows Arch. 2018 May;472(5):749-758. doi: 10.1007/s00428-018-2354-9. Epub 2018 Apr 13. Virchows Arch. 2018. PMID: 29654370 Free PMC article.

3

Microsatellite instability, KRAS mutations and cellular distribution of TRAIL-receptors in early stage colorectal cancer.

Kriegl L, Jung A, Horst D, Rizzani A, Jackstadt R, Hermeking H, Gallmeier E, Gerbes AL, Kirchner T, Göke B, De Toni EN. Kriegl L, et al. Among authors: horst d. PLoS One. 2012;7(12):e51654. doi: 10.1371/journal.pone.0051654. Epub 2012 Dec 20. PLoS One. 2012. PMID: 23284732 Free PMC article.

4

Prognostic value and association with epithelial-mesenchymal transition and molecular subtypes of the proteoglycan biglycan in advanced bladder cancer.

Schulz GB, Grimm T, Sers C, Riemer P, Elmasry M, Kirchner T, Stief CG, Karl A, Horst D. Schulz GB, et al. Among authors: horst d. Urol Oncol. 2019 Aug;37(8):530.e9-530.e18. doi: 10.1016/j.urolonc.2019.05.011. Epub 2019 Jun 5. Urol Oncol. 2019. PMID: 31176613

5

EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer.

Rose M, Maurer A, Wirtz J, Bleilevens A, Waldmann T, Wenz M, Eyll M, Geelvink M, Gereitzig M, Rüchel N, Denecke B, Eltze E, Herrmann E, Toma M, Horst D, Grimm T, Denzinger S, Ecke T, Vögeli TA, Knuechel R, Maurer J, Gaisa NT. Rose M, et al. Among authors: horst d. Oncogene. 2020 Oct;39(44):6856-6870. doi: 10.1038/s41388-020-01465-y. Epub 2020 Sep 25. Oncogene. 2020. PMID: 32978523 Free PMC article.

6

Therapeutic and prognostic implications of NOTCH and MAPK signaling in bladder cancer.

Schulz GB, Elezkurtaj S, Börding T, Schmidt EM, Elmasry M, Stief CG, Kirchner T, Karl A, Horst D. Schulz GB, et al. Among authors: horst d. Cancer Sci. 2021 May;112(5):1987-1996. doi: 10.1111/cas.14878. Epub 2021 Mar 31. Cancer Sci. 2021. PMID: 33686706 Free PMC article.

7

Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancer.

Moisoiu T, Dragomir MP, Iancu SD, Schallenberg S, Birolo G, Ferrero G, Burghelea D, Stefancu A, Cozan RG, Licarete E, Allione A, Matullo G, Iacob G, Bálint Z, Badea RI, Naccarati A, Horst D, Pardini B, Leopold N, Elec F. Moisoiu T, et al. Among authors: horst d. Mol Med. 2022 Apr 1;28(1):39. doi: 10.1186/s10020-022-00462-z. Mol Med. 2022. PMID: 35365098 Free PMC article.

8

Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options.

Jurmeister P, Vollbrecht C, Behnke A, Frost N, Arnold A, Treue D, Rückert JC, Neudecker J, Schweizer L, Klauschen F, Horst D, Hummel M, Dietel M, von Laffert M. Jurmeister P, et al. Among authors: horst d. Lung Cancer. 2019 Dec;138:43-51. doi: 10.1016/j.lungcan.2019.10.005. Epub 2019 Oct 11. Lung Cancer. 2019. PMID: 31634654

9

Recurrence of Hepatocellular Carcinoma After Liver Transplantation is Associated with Episodes of Acute Rejections.

Gül-Klein S, Kästner A, Haber PK, Krenzien F, Wabitsch S, Krannich A, Andreou A, Eurich D, Tacke F, Horst D, Pratschke J, Schmelzle M. Gül-Klein S, et al. Among authors: horst d. J Hepatocell Carcinoma. 2021 Mar 18;8:133-143. doi: 10.2147/JHC.S292010. eCollection 2021. J Hepatocell Carcinoma. 2021. PMID: 33777855 Free PMC article.

10

γ-Catenin is an independent prognostic marker in early stage colorectal cancer.

Nagel JM, Kriegl L, Horst D, Engel J, Gautam S, Mantzoros CS, Kirchner T, Göke B, Kolligs FT. Nagel JM, et al. Among authors: horst d. Int J Colorectal Dis. 2010 Nov;25(11):1301-9. doi: 10.1007/s00384-010-1046-y. Epub 2010 Aug 25. Int J Colorectal Dis. 2010. PMID: 20737155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters